Ahren, Bo, Atkin, Stephen L, Charpentier, Guillaume, Warren, Mark L, Wilding, John PH ORCID: 0000-0003-2839-8404, Birch, Sune, Holst, Anders Gaarsdal and Leiter, Lawrence A
(2018)
Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials.
DIABETES OBESITY & METABOLISM, 20 (9).
2210 - 2219.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | BMI, gastrointestinal adverse events, GLP-1 analogue, GLP-1 based therapy, nausea, type 2, vomiting, weight control, weight loss |
Depositing User: | Symplectic Admin |
Date Deposited: | 20 Jul 2018 10:20 |
Last Modified: | 22 Jan 2021 16:10 |
DOI: | 10.1111/dom.13353 |
Open Access URL: | https://onlinelibrary.wiley.com/doi/epdf/10.1111/d... |
Related URLs: | |
URI: | https://livrepository.liverpool.ac.uk/id/eprint/3023979 |
Dimensions
Altmetric
Share
CORE (COnnecting REpositories)